Financial Performance - China Life's Q3 2025 revenue and net profit attributable to shareholders increased by 54.8% and 91.5% year-on-year, reaching 298.7 billion and 126.9 billion respectively, driving year-to-date revenue and net profit growth to 25.9% and 60.5% [1] - The company's net assets attributable to shareholders grew by 22.8% year-to-date to 625.8 billion by the end of Q3, outperforming peers whose growth ranged from -2.5% to 16.9% [1] - The total investment return rate increased by 104 basis points year-on-year to 6.42% [1] Business Development - New policy sales showed a significant improvement, with new premium growth accelerating from -4.5% in Q1 2025 to 10.4% in Q1-3 2025, and Q3 alone saw a strong growth of 52.5% [2] - The new business value (NBV) growth rate also improved, rising from 4.8% in Q1 2025 to 41.8% in Q1-3 2025, attributed to a strong individual insurance sales team and effective marketing strategies [2] Investment Performance - Total investment income for the first three quarters of 2025 increased by 41% to 368.6 billion, with a total investment return rate of 6.42% [2] - The company likely benefited from an increase in equity investments and capitalized on the growth stock market in Q3 2025 [2] Profit Forecast - The company forecasts net profits for 2025-2027 to be 173.5 billion, 153.8 billion, and 186.4 billion respectively, with year-on-year growth rates of 62%, -11.4%, and 21.2% [3] - The estimated embedded value per share for 2025-2027 is projected to be 57.1, 60.2, and 65.3 yuan, with current price-to-embedded value (PEV) ratios of 0.75, 0.71, and 0.66 [3]
中国人寿(601628)季报点评:新单销售逐季强劲改善 投资收益表现出色